Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4374381 | 0.94 | TSHR (0.44) | TSHRRECQLCYP3A4ATMTDP1 | |
| Acrylic Acid SCHEMBL5062877 | 0.90 | TSHR (0.45) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL2278328 | 0.87 | TSHR (0.39) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL2281296 | 0.87 | TSHR (0.39) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL7259706 | 0.84 | TSHR (0.51) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL3249371 | 0.83 | TSHR (0.43) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL2279931 | 0.81 | TSHR (0.33) | TSHRCYP3A4ATMTDP1 | |
| SCHEMBL22081 | 0.80 | CA2 (0.47) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL20609791 | 0.80 | CA2 (0.47) | TSHRRECQLCYP3A4ATMTDP1 | |
| SCHEMBL2284258 | 0.79 | TSHR (0.39) | TSHRRECQLCYP3A4ATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989654-B2 | High purity bases of 3,3-diphenylpropylamino monoesters | UCB PHARMA GMBH (DE) | 2011-08-02 | — | — | US | disclosed |
| US-20090012159-A1 | HIGH PURITY BASES OF 3,3-DIPHENYLPROPYLAMINO MONOESTERS | UCB PHARMA GMBH (DE) | 2009-01-08 | — | — | US | disclosed |
| US-20060014832-A1 | Highly pure bases of 3,3-dipheyl propylamine monoesters | SCHWARZ PHARMA AG (DE) | 2006-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014832-A1 | Highly pure bases of 3,3-dipheyl propylamine monoesters | ADRB3, DRD3, CYP3A5 | TSHR 567/4885RECQL 924/4885CYP3A4 76/4885 |
| US-20090012159-A1 | HIGH PURITY BASES OF 3,3-DIPHENYLPROPYLAMINO MONOESTERS | CYP11B2, CYP11B1, CYP21A2 | TSHR 474/4885RECQL 1970/4885CYP3A4 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.